Clinical Trials | June 23, 2026
Pfizer lung cancer drug misses key survival goal in Phase 3 trial
The company said the safety profile remained consistent with earlier studies and was considered manageable
The company said the safety profile remained consistent with earlier studies and was considered manageable
Patnaik stressed early diagnosis, rapid treatment, and aggressive surveillance as the backbone of elimination efforts
The company stated that it will work closely with the regulator to address the observations within the stipulated timeframe
The study included four independent genetic substudies targeting obesity caused by heterozygous variants in the POMC/PCSK1, LEPR, SRC1 (NCOA1), and SH2B1 genes
There are limited treatment options available for patients living with non-diabetic CKD, and the unmet need is high for new treatments to delay kidney disease progression and reduce cardiovascular risk
The EIR was issued following an inspection of the facility from November 10 to November 21, 2025
Lupin will address the observations and respond to the U.S. FDA within the stipulated timeframe
The said inspection concluded with Zero Form 483 observation
We are taking Ayurveda to the world as a sustainable healthcare solution: Union Minister Prataprao Jadhav
The trial is the largest to date evaluating Leqvio and the first to focus on patient-centered outcomes
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
